middle.news
How Will Rhythm’s 4Cyte Deal Boost ColoSTAT® Colorectal Cancer Testing?
8:48am on Tuesday 17th of February, 2026 AEDT
•
Healthcare
Read Story
How Will Rhythm’s 4Cyte Deal Boost ColoSTAT® Colorectal Cancer Testing?
8:48am on Tuesday 17th of February, 2026 AEDT
Key Points
Non-exclusive ColoSTAT® distribution agreement with 4Cyte Pathology
Access to over 1,000 patient collection centres in NSW, Victoria, and Queensland
Testing performed at Rhythm’s ISO-accredited laboratory in Parkville
No upfront payments or minimum volume commitments under the agreement
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
RHYTHM BIOSCIENCES (ASX:RHY)
OPEN ARTICLE